Gyan Brard, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 217 S 63rd St, Suite 105, Mesa, AZ 85206 Phone: 480-981-8088 Fax: 480-981-3883 |
Shahzad Shadmany, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 217 S 63rd St, Suite 105, Mesa, AZ 85206 Phone: 480-981-8088 Fax: 480-981-3883 |
Dr. Cho Long Elizabeth Kim, N.M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 108 E 2nd Ave, Mesa, AZ 85210 Phone: 480-584-2677 |
Dr. Joseph Khatchadourian, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 4140 E Baseline Rd Ste 101, Mesa, AZ 85206 Phone: 480-719-6229 |
Robert Charles Biesbroeck, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 217 S 63rd St, Suite 105, Mesa, AZ 85206 Phone: 480-981-8088 Fax: 480-981-3883 |
News Archive
In one of the largest epidemiological studies of human gut bacteria and colorectal cancer ever conducted, a team of researchers at NYU Langone Medical Center has found a clear association between gut bacteria and colorectal cancer. The study, published today in the Journal of the National Cancer Institute, discovered that colorectal cancer patients had fewer beneficial bacteria and more harmful bacteria than people without the disease.
In recognition of World AIDS Day, held annually on Dec. 1 each year since 1988, the Forum of International Respiratory Societies (FIRS) is calling on governments, health advocates and non-government organizations to strengthen their response to HIV/AIDS. In 2015 AIDS claimed 1.1 million lives.
Touch a hot stove, and your fingers will recoil in pain because your skin carries tiny temperature sensors that detect heat and send a message to your brain saying, "Ouch! That's hot! Let go!"
Researchers at Imperial College London in the UK have reported on round five of the REal-time Assessment of Community Transmission-2 (REACT-2) program – a cross-sectional community survey measuring the prevalence of antibodies against the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among adults in England.
Vivolux AB, a drug discovery company specialized in cancer treatment, announced today that data that forms the basis for one of the company's promising projects has been published in the journal Nature Medicine. Researchers at the Karolinska Institute have discovered a novel cancer drug target.
› Verified 7 days ago